{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:1ce74039-c28d-4e61-8266-421b21c000d9", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-11-19T21:05:42.582082Z", "firstcreated": "2026-11-19T21:05:23.587681Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "Pfizer ends Canadian sales of Premarin menopause drug while U.S. supply continues", "byline": "", "located": "CA", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / The Canadian Public Chronicle", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "Pfizer has discontinued its Canadian-made Premarin menopause tablets and vaginal cream, though production for U.S. patients will continue, leaving Canadian women to rely on alternatives.", "altids": {"mosaic": "1ce74039-c28d-4e61-8266-421b21c000d9", "story": "0ea1aa8c-b602-4958-b295-1dc1810ea3b9", "slug": "pfizer-ends-canadian-sales-of-premarin-menopause-drug-while-u-s-supply-continues"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "CA", "literal": "ca", "code": "CA", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "Pfizer has discontinued its Canadian-made Premarin menopause tablets and vaginal cream, though production for U.S. patients will continue, leaving Canadian women to rely on alternatives.", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:c55f9273-d8ad-422d-9710-003d8fbe0adf", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Menopause drug made in Canada won’t be available to Canadians, but still sold in U.S.", "description_text": "Pfizer ends Canadian sales of Premarin menopause drug while U.S. supply continues", "copyrightholder": "commons.wikimedia.org", "copyrightnotice": "Kwamikagami", "usageterms": "Open licence: the credit line must travel with the file.", "altids": {"wireva": "c55f9273-d8ad-422d-9710-003d8fbe0adf"}, "extra": {"wireva:delivery_mode": "file", "wireva:rights": {"licence": "CC BY-SA 4.0", "licence_url": "https://creativecommons.org/licenses/by-sa/4.0/", "licence_raw": "CC BY-SA 4.0", "licence_verified_at": "2026-11-19T21:05:42.597848Z", "attribution_required": true, "attribution_text": "Kwamikagami", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": true}, "wireva:provenance": {"creator": "", "source_name": "commons.wikimedia.org", "source_url": "https://commons.wikimedia.org/wiki/File:Menopause_symbol.svg", "source_page_url": "https://commons.wikimedia.org/wiki/File:Menopause_symbol.svg", "our_page_url": "https://canadianchronicle.com/society/pfizer-ends-canadian-sales-of-premarin-menopause-drug-while-u-s-supply-continues/"}, "wireva:role": "lead"}, "renditions": {"original": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/c4fea125ab0ae2cd31765a2910cd062f6609d60b834ab0b5209bec20f7c003f8.jpg", "mimetype": "image/jpeg", "width": 900, "height": 900, "sizeinbytes": 20834}, "source": {"href": "https://commons.wikimedia.org/wiki/File:Menopause_symbol.svg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:0ea1aa8c-b602-4958-b295-1dc1810ea3b9", "slug": "pfizer-ends-canadian-sales-of-premarin-menopause-drug-while-us-supply-continues-20261119", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / The Canadian Public Chronicle", "canonical_required": true, "canonical_url": "https://canadianchronicle.com/society/pfizer-ends-canadian-sales-of-premarin-menopause-drug-while-u-s-supply-continues/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "failed", "score": 0.816, "checked_at": "2026-11-19T21:05:42.595333Z"}}, "wireva:publication": {"name": "The Canadian Public Chronicle", "domain": "canadianchronicle.com", "country": "CA", "url": "https://canadianchronicle.com/society/pfizer-ends-canadian-sales-of-premarin-menopause-drug-while-u-s-supply-continues/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/1ce74039-c28d-4e61-8266-421b21c000d9", "html": "https://wireva.mib.news/item/1ce74039-c28d-4e61-8266-421b21c000d9/pfizer-ends-canadian-sales-of-premarin-menopause-drug-while-u-s-supply-continues/", "story": "https://wireva.mib.news/story/pfizer-ends-canadian-sales-of-premarin-menopause-drug-while-us-supply-continues-20261119/"}, "wireva:metrics": {"word_count": 461, "char_count": 2936, "reading_time_seconds": 210}}}